Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) has earned an average rating of "Moderate Buy" from the eleven ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, four have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $129.33.
ADUS has been the subject of a number of analyst reports. Raymond James Financial set a $137.00 price objective on shares of Addus HomeCare in a research report on Monday, September 28th. Bank of America reaffirmed a "neutral" rating and issued a $125.00 target price (down from $140.00) on shares of Addus HomeCare in a report on Monday, September 14th. Barclays raised their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an "underweight" rating in a research note on Wednesday, July 8th. Royal Bank Of Canada raised their target price on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. Finally, Citigroup cut Addus HomeCare from a "market outperform" rating to a "neutral" rating in a report on Monday, September 14th.
Check Out Our Latest Stock Report on Addus HomeCare
Addus HomeCare Price Performance
NASDAQ:ADUS opened at $115.47 on Tuesday. The stock has a market capitalization of $2.16 billion, a PE ratio of 20.26, a P/E/G ratio of 1.63 and a beta of 0.83. Addus HomeCare has a 1-year low of $87.95 and a 1-year high of $124.43. The firm has a fifty day simple moving average of $116.51 and a 200 day simple moving average of $104.99. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping analysts' consensus estimates of $1.70 by $0.03. The business had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm's revenue for the quarter was up 8.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.49 earnings per share. On average, research analysts expect that Addus HomeCare will post 6.30 EPS for the current fiscal year.
Institutional Trading of Addus HomeCare
Several institutional investors and hedge funds have recently bought and sold shares of the business. NFJ Investment Group LLC acquired a new position in shares of Addus HomeCare in the second quarter valued at $29,000. Caitong International Asset Management Co. Ltd raised its position in shares of Addus HomeCare by 73.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 325 shares of the company's stock valued at $35,000 after purchasing an additional 138 shares during the period. Parallel Advisors LLC lifted its stake in shares of Addus HomeCare by 66.3% during the 1st quarter. Parallel Advisors LLC now owns 404 shares of the company's stock worth $38,000 after buying an additional 161 shares during the last quarter. State of Wyoming acquired a new stake in shares of Addus HomeCare during the 2nd quarter worth about $79,000. Finally, Persistent Asset Partners Ltd acquired a new stake in shares of Addus HomeCare during the 2nd quarter worth about $98,000. Institutional investors own 95.35% of the company's stock.
About Addus HomeCare
(
Get Free Report)
Addus HomeCare Corporation is a provider of home-based health care and support services for older adults, people with disabilities and other individuals who require assistance at home. The company's services are designed to help clients maintain independence and avoid or delay institutional care.
Addus operates through three primary service lines: personal care, home health and hospice. Personal care services include assistance with daily activities such as bathing, dressing, meal preparation and mobility.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.